89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,734 | -70.8% | 760 | -64.1% | 0.00% | – |
| Q2 2023 | $40,117 | -34.8% | 2,117 | -47.6% | 0.00% | – |
| Q1 2023 | $61,530 | +132.5% | 4,040 | +94.3% | 0.00% | – |
| Q4 2022 | $26,466 | +120.6% | 2,079 | 0.0% | 0.00% | – |
| Q3 2022 | $12,000 | +71.4% | 2,079 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -99.7% | 2,079 | -99.7% | 0.00% | – |
| Q1 2022 | $2,684,000 | -67.8% | 712,210 | +11.7% | 0.00% | -100.0% |
| Q4 2021 | $8,332,000 | -34.7% | 637,526 | -2.1% | 0.00% | 0.0% |
| Q3 2021 | $12,757,000 | +1.8% | 651,200 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $12,527,000 | +22.2% | 669,870 | +54.7% | 0.00% | 0.0% |
| Q1 2021 | $10,254,000 | -7.3% | 433,040 | -4.6% | 0.00% | 0.0% |
| Q4 2020 | $11,058,000 | +2143.0% | 453,740 | +2263.2% | 0.00% | – |
| Q3 2020 | $493,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |